Global Parenteral Nutrition Market Segmentation, By Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals), Consumer Type (Children and New-born, Adults), End-User (Clinic, Hospital, and Others) – Industry Trends and Forecast to 2032.
Parenteral Nutrition Market Analysis
The body receives nutrients from parenteral nourishment, including sugar, carbs, proteins, fats, electrolytes, and trace elements. These nutrients are essential for preserving high levels of strength, hydration, and energy.
Parenteral Nutrition Market Size
Global parenteral nutrition market size was valued at USD 7.31 billion in 2024 and is projected to reach USD 10.89 billion by 2032, with a CAGR of 5.10% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Parenteral Nutrition Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Baxter (U.S.), Otsuka Pharmaceutical Factory, Inc. (Tokyo), Forbes Media LLC (U.S.), Kelun.com (China), Vifor Pharma Management Ltd. (Switzerland), AbbVie Inc. (U.S.), B.Braun Melsungen AG (Germany), Fresenius SE & Co. KGaA (Germany), Grifols S.A. (Spain), Pfizer, Inc. (U.S.), ICU Medical, Inc. (U.S.), Anhui Medipharm Co., Ltd. (China), aculife (India), Servona GmbH (Germany)
|
|
Market Opportunities
|
|
Parenteral Nutrition Market Definition
In both developing and established economies, malnourishment is a major contributor to inflammatory bowel disease (IBD), which affects a significant portion of the population. On a larger scale, total parenteral nutrition (TPN) serves as a major treatment for IBD by addressing the nutritional shortage brought by the conclusion of intestinal failure.
Parenteral Nutrition Market Dynamics
Drivers
- Rising metabolic disorders
One of the key factors driving the expansion of the parenteral nutrition market in the present is the rise in metabolic disorders along with chronic diseases like diabetes. The parenteral nutrition industry will expand as a result of the rising rate of malnutrition in the world. Additionally, one of the main factors driving the expansion of the parenteral nutrition market is the ageing population, which is increasing.
- Increasing chronic diseases
Rapid modernization, poor dietary intake of a balanced diet, and the rising frequency of chronic diseases all contribute to the need for the parenteral nutrition industry.
- Increasing prevalence of malnutrition
The need for parenteral nutrition has increased as a result of the rising incidence of malnutrition around the world. This demand is anticipated to favourably influence the industry's development. Additionally, there was a strong demand for intravenous feeding as a result of the supportive government initiatives to lessen the impact of malnutrition.
Opportunities
The rise in childhood malnutrition, particularly in developing and emerging economies worldwide, is anticipated to fuel the growth of the parenteral nutrition market. Additionally, the parenteral nutrition industry would have promising growth prospects due to the need for parenteral nutrition to properly balance amino acids, lipids, vitamins, minerals, and other nutrients.
Restraints/Challenges
Despite this, the acceptability of parenteral feeding products is subject to stringent government regulations, particularly in emerging economies, which will restrain the market's expansion. One of the main obstacles to the growth of the parenteral nutrition industry in the anticipated term is the lack of information among people in developed nations.
This parenteral nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parenteral nutrition market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Parenteral Nutrition Market
The parenteral nutrition market value has been impacted by the extraordinary global health issue caused by the COVID-19 virus outbreak. Parenteral nutrition played a crucial part in the treatment of malnutrition caused by the COVID-19 infection in patients all over the world. A severe lack of appetite brought on by the COVID-19 infection was accompanied by other symptoms that worsened immune defences and caused muscle mass loss. In response to this illness, hospitals and clinics have increased the number of healthcare facilities available for patients who need diet tailored to their sickness. Such advancements are likely to increase patient demand for and adoption of intravenous nutrition administration.
Parenteral Nutrition Market Scope
The parenteral nutrition market is segmented on the basis of nutrition type, consumer type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Nutrient Type
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Consumer Type
- Children and New-born
- Adults
End-User
- Clinic
- Hospital
- Others
Parenteral Nutrition Market Regional Analysis
The parenteral nutrition market is analyzed and market size insights and trends are provided by country, nutrition type, consumer type, and end-user as referenced above.
The countries covered in the parenteral nutrition market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the parenteral nutrition market due to the importance of huge research costs by government agencies and private entities in the healthcare sector.
Asia-Pacific region is anticipated to increase over the course of the forecast period as a result of the economic development of emerging nations and appropriate government initiatives to improve healthcare infrastructure and reimbursement practices.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Parenteral Nutrition Market Share
The parenteral nutrition market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to parenteral nutrition market.
Parenteral Nutrition Market Leaders Operating in the Market Are:
- Baxter (U.S.)
- Otsuka Pharmaceutical Factory, Inc. (Tokyo)
- Forbes Media LLC (U.S.)
- Kelun.com (China)
- Vifor Pharma Management Ltd. (Switzerland)
- AbbVie Inc. (U.S.)
- B.Braun Melsungen AG (Germany)
- Fresenius SE & Co. KGaA (Germany)
- Grifols S.A. (Spain)
- Pfizer, Inc. (U.S.)
- ICU Medical, Inc. (U.S.)
- Anhui Medipharm Co., Ltd. (China)
- aculife (India)
- Servona GmbH (Germany)
Latest Developments in Parenteral Nutrition Market
- In July 2021, Micrel Medical, a manufacturer of medical devices with a focus on infusion therapy, and Baxter Healthcare (Baxter) inked a contract. In accordance with this agreement, the businesses would market the infusion pump Micrel Mini Rythmic PN+ for parenteral nutrition (PN).
- Sep 2020, The U.S. Food and Drug Administration (FDA) gave its approval to Baxter International's new Clinimix Injections and Clinimix E Injections formulations. It is easier to reach patient protein targets with the new Clinimix formulations because they contain up to 80 g/L of amino acids, the highest amount of protein in any multi-chamber bag currently available in the United States also contain less fluid and dextrose than previous formulations.
SKU-